Full Text View
Tabular View
No Study Results Posted
Related Studies
Effect of Alphagan on Retinal Blood Flow Autoregulation and Motion Detection in Patients With Normal Pressure Glaucoma
This study is ongoing, but not recruiting participants.
Study NCT01105065   Information provided by Massachusetts Eye and Ear Infirmary

First Received on April 14, 2010.   Last Updated on February 13, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Glaucoma
Additional conditions recognized in this trial
Low Tension Glaucoma
More general conditions related to this trial
Eye Diseases
Ocular Hypertension
Optic Nerve Diseases
Interventions listed in this trial
Alphagan (brimonidine) 0.15%
Additional drug interventions recognized in this trial
Brimonidine
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Agonists
Adrenergic alpha-2 Receptor Agonists
Adrenergic alpha-Agonists
Antihypertensive Agents
Cardiovascular Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Massachusetts Eye and Ear Infirmary


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services